 |
|
|
| |
Early Implementation and Clinical Outcomes of Long-Acting Injectable Cabotegravir and Rilpivirine in a Safety-Net Clinic
|
| |
| |
AIDS 2022 July 29-Aug 2 Montreal
K. Christopoulos 1, J. Grochowski 1, M. Hickey 1, E. Imbert 1, J. Szumowski 1, S. Dilworth 1, J. Briggs 1,
J. Oskarsson 1, M. Shiels 1, F. Mayorga-Munoz 1, D. Havlir 1, M. Gandhi 1
1University of California San Francisco, San Francisco, United States
|
| |
|
|
|
|
|
